ArticlePloS one2014

Antileukemic activity of sulforaphane in primary blasts from patients affected by myelo- and lympho-proliferative disorders and in hypoxic conditions.

Carmela Fimognari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.